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What is already known on this topic? 
 Paediatric dilated cardiomyopathy (DCM) is the commonest of the childhood 
cardiomyopathies, with significant associated morbidity and mortality. 
 DCM is most commonly idiopathic. 
 DCM secondary to vitamin D deficiency is rare but readily treatable and reversible.  
What this study adds? 
 Identifying the aetiology of DCM in the paediatric population aids risk stratification 
and prognostication. 
 Regardless of aetiology, the first year after diagnosis of DCM is associated with 
significant mortality. 
 Males are significantly less likely to survive to one year post diagnosis. 
 The survival from DCM in the paediatric population in Scotland has improved in the 
modern era. 
Abstract 
 
Background 
Dilated cardiomyopathy (DCM) is the most common form of the childhood cardiomyopathies 
and is known to result in significant morbidity and mortality in the paediatric population 1,2.  
Objective 
To review the aetiology and associated outcomes of DCM in Scottish children. 
Methods 
A retrospective data review of 43 consecutive cases of DCM diagnosed in a national paediatric 
cardiology centre from 1st September 2000 - 1st September 2015.  All paper and electronic case 
notes were reviewed to identify the aetiology; age at presentation; need for intensive care i.e. 
mechanical ventilation; inotropic support; extra-corporeal life support (ECLS); cardiac 
transplantation; and to report the longer term outcomes. 
Results 
43 patients were diagnosed with DCM during the study period. The median age at diagnosis 
was 10 months (range = 0-42months); 28 (65%) cases were diagnosed within the first year of 
life and 42 (98%) cases were diagnosed before the child’s second birthday.  25 cases were 
female, 18 were male; with a male: female ratio of 1:1.4. In the cohort 82% were Caucasian; 
9% Black and 9% of Asian ethnicity. Over half the cases (51%) were idiopathic; 23% 
secondary to a viral infection; 16% metabolic or genetic disorders and 10% as a result of 
vitamin D deficiency.  Parvovirus B19 was the most common infectious agent identified in 
60% of cases, with an additional 30% secondary to enteroviruses. 60% of the children required 
inotropic support and extra corporeal life support was administered in 19% of cases.  Six of the 
18 (30%) males died; one MYH7 gene positive; one long chain fatty oxidation disorder; one 
viral and three idiopathic DCM. Only one (4%) of the 25 females did not survive, and males 
were significantly less likely to survive to one year of age p = 0.015.  The median age at 
diagnosis did not alter survival to one year and the estimated survival proportion in the cohort 
beyond one year was 83.7% (95% CI, 71.3 to 94.5%), with all deaths occurring within one year 
of presentation. 
Conclusion 
Paediatric dilated cardiomyopathy is a heterogeneous disease resulting in significant morbidity. 
In the paediatric population the aetiology alters the age at presentation and identification is also 
a useful tool for risk stratification and prognostication. DCM is idiopathic in around 50% of 
cases.  The first year after diagnosis is a critical time reflected in significant morbidity and 
mortality.  
Introduction  
Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy in children3; 
defined by the World Health Organization as a disorder ‘characterized by dilation and impaired 
contraction of the left ventricle or both ventricles’ in the presence of normal wall thickness 1,2. 
The onset of the disease may be subtle and insidious, or alternatively acute and life threatening. 
At initial presentation DCM may be mistakenly diagnosed as an isolated respiratory tract 
infection or viral illness, and not initially considered a differential diagnosis unless 
cardiomegaly is detected on a chest x-ray; failure to respond to conventional supportive 
management or profound cardiovascular collapse.  Despite advances in the diagnosis and 
medical management of paediatric DCM, the morbidity, mortality and impact on hospital 
admissions remains significant4. The aim of our study was to review the aetiology of dilated 
cardiomyopathy and the associated outcomes in the Scottish paediatric population. 
 
Methods 
A retrospective data review of 43 consecutive cases of DCM, aged <18 years, diagnosed in the 
Scottish national paediatric cardiology centre from the 1st September 2000 - 1st September 
2015.  The departmental database Heartsuite (Heartsuite, Systeria, Glasgow, UK) was used to 
identify patients and provide initial patient data. In addition, electronic and paper case notes 
were reviewed to identify the age at presentation; aetiology, need for intensive care support; 
mechanical ventilation; inotropic support; extra-corporeal life support (ECLS); cardiac 
transplantation and the associated long term mortality. In order to determine potential links 
between deprivation and the incidence of DCM, the Scottish Index of Multiple Deprivation 
(SIMD) was utilized. SIMD is a tool employed by the Scottish Government to identify areas 
of multiple deprivation in Scotland. The index scores Scottish regions from one to five, where 
five indicates the lowest level of deprivation.  
 Patients with structural heart disease, cardiomyopathy secondary to sustained arrhythmias; 
coronary artery disease, or anthracycline toxicity were excluded from the study.  Diagnosis was 
based upon clinical features of heart failure and echocardiographic evidence of global systolic 
dysfunction; left ventricular diastolic dimensional Z score of more than two standard deviations 
above normal, and a fractional shortening (FS) less than 25%. Global speckle strain imaging is 
currently used in our centre to monitor systolic function, however this modality was not utilised 
routinely in the early cohort.  Transthoracic echocardiography was used as a diagnostic tool 
and to monitor disease progression. Measurements of left ventricular cavity and wall-thickness 
at end diastole, end systole, as well as estimation of fractional shortening and ejection fraction 
were documented in all cases.  Resolution of DCM was defined in the absence of clinical 
features of heart failure; normal cardiac function and normal left ventricular dimensions 
reported by transthoracic echocardiography.  
As the study sample was small, statistical significance tests i.e. Mann-Whitney test, Pearson 
Chi-Square test and Fisher’s exact test were employed in the analysis of contingency tables. 
These logistic tests were used to evaluate the significance of aetiologies, age at presentation, 
gender, ethnicity, deprivation, season at presentation, inotrope usage, invasive mechanical 
ventilation, extra corporeal life support (ECLS) and heart transplant related to outcomes.  
 
Results 
43 consecutive patients were diagnosed with DCM during the study period; the demographics 
are illustrated in Table 1. The median age at diagnosis was 10 months (range 0-42 months) 
with 28 (65%) patients diagnosed within the first year of life and 42 (98%) cases diagnosed in 
children before their second birthday (Figure 1).  DCM was more common among girls, 25 
(58%) cases of DCM compared to 18 (42%) in the male population. Male: female ratio 1:1.4.  
Survival to one year after the initial diagnosis was significantly lower in the male population 
(p=0.015) as only one (4%) female in the cohort did not survive. In the cohort, 82% were 
Caucasian; 9% Black and 9% of Asian ethnicity. The median SIMD score was three and further 
analysis did not demonstrate a significant association between the SIMD and incidence or 
mortality associated with DCM.  
Presenting Features 
The presenting clinical features varied in severity: 60% (n=26) had overt signs of heart failure 
- three patients presenting with heart failure had severe cardiovascular compromise requiring 
paediatric intensive care admission; 14% (n=6) had isolated respiratory symptoms at 
presentation; 14% (n=6) presented with failure to thrive and feeding difficulties. Other 
presenting signs or symptoms included: supraventricular tachycardia 2% (n=1); heart murmur 
2% (n=1) and seizures 2% (n=1). Two (4%) asymptomatic patients with a family history of 
DCM were detected routinely during familial screening.  
Aetiology 
51% of DCM cases were classified as idiopathic, therefore no cause was identified. In several 
cases the children presented with signs and symptoms of a viral illness, but despite extensive 
virology work up no viruses were isolated. Endomyocardial biopsy was not routinely 
undertaken in our patients. A viral aetiology was the most common identifiable cause of DCM, 
evident in 23% of cases: 60% of which were secondary to Parvovirus B19; and 30% due to 
enteroviruses (Figure 2).  There was evidence of seasonal variation, with an increased incidence 
of DCM diagnosis in autumn n=18, (42%) (Figure 3,4). 16% (n=7) of DCM cases were as a 
consequence of a metabolic or genetic abnormality: MYH7 gene mutation n=3; Barth’s 
syndrome n=1; combination of Barth’s syndrome and MYH7 gene mutation n=1; long chain 
CoA dehydrogenase deficiency n=1, I-cell disease (MPS type II) n=1. Within the metabolic 
and genetic cohort, the male to female ratio was higher 6:1 in comparison to the total 
population, male: female 1:1.4. Due to the small sample size the Chi-square test was not 
significant. Vitamin D deficiency was reported in 10% (n=4) of DCM cases, with a median age 
at diagnosis of 4.5 months compared to 10 months in the full cohort (Figure 1); three children 
were of Asian or Black descent and only one was Caucasian. All cases of vitamin D deficient 
DCM patients achieved full recovery after receiving appropriate supplementation, including 
one child requiring ECLS as a bridge to recovery.   
N=26 (60%) of the DCM population required inotropic support, n=19 (44%) required 
mechanical ventilation and N=8 (19%) required ECLS as a bridge to recovery or cardiac 
transplant, of which six patients survived and made a full clinical and echocardiographic 
recovery. Transplantation is routinely discussed with families in the presence of escalating 
intensive care support and cardiovascular instability. In our population, 18 families (42%) 
consented to transplant referral.  Of the patients discussed, n=7 were placed on the non-active 
transplant list, and all were subsequently removed from the list after resolution of the DCM. In 
contrast, a total of 11 were accepted onto the active transplant list: n=4 restored normal cardiac 
function and were subsequently removed from the list; n=4 died awaiting transplant and n=3 
were successfully transplanted and all are alive to date (Figure 5).  
Unfortunately, our sample size was too small for formal statistical analysis to suggest such 
association between aetiology and survival. 
Mortality   
The reported survival from initial diagnosis to one year post diagnosis was 83.7% (95% CI, 
71.3 to 94.5%), the median age at diagnosis did not alter survival to one year and 
observationally more deaths occurred in the winter months but the sample size was too small 
for formal statistical analysis. Males were more likely to have DCM secondary to a genetic and 
metabolic disorders (P-Value = 0.020) and were statistically less likely to survive one year 
from diagnosis (P-Value = 0.015).  Six (30%) males died within the first year of diagnosis; one 
MYH7 gene positive, one long chain fatty oxidation disorder, one of viral aetiology and three 
idiopathic DCM.  In contrast only one (4%) female died within the first year of diagnosis 
secondary to idiopathic DCM.  Children requiring ECLS were less likely to survive, but this 
did not reach statistical significance at the 95% CI level (P-Value = 0.106) due to the smaller 
sample size. 
 
Discussion 
Dilated cardiomyopathy is a heterogeneous disease with reported prevalence in the paediatric 
population ranging from 1 in 140 000 in Australia to 1 in 170 000 in the US5. Some milder 
cases of dilatation may be detected during familial screening for DCM as in our cohort, 
however the majority of children with DCM are symptomatic at presentation. In the future, 
wider use of genetic testing may identify asymptomatic carriers of DCM in the paediatric 
population. Recent advances have been made in the understanding of the genetic aetiology of 
DCM. Hershberger et al identified more than 30 genes of various ontologies which are thought 
to contribute to approximately 40- 50% of the genetic causes of DCM6,7.  
Despite these advances a significant proportion of paediatric DCM cases remain classified as 
idiopathic, in some studies as many as 66% of reported cases8. Our study confirms that a 
significant proportion of DCM in the paediatric population is idiopathic despite comprehensive 
metabolic, genetic investigations and viral PCRs. An endomyocardial biopsy is not a first line 
investigation for DCM within our cardiac centre, thus in some cases a viral aetiology may not 
have been identified. Identifying an aetiology, where possible, is a useful tool for clinicians to 
provide risk stratification and prognostication for families. This is particular true in the rarer 
cause of dilated cardiomyopathy, secondary to vitamin D deficiency. Vitamin D is a steroid 
hormone which binds nuclear receptors in the heart altering gene transcription9. Exposure of 
ultraviolet radiation on the skin is a crucial source of vitamin D and ethnic groups with darker 
skin in the UK are at greater risk, particularly between October to the beginning of April10. A 
retrospective review by Maiya et al identified 16 paediatric patients with DCM secondary to 
vitamin D deficiency over a 6-year period in the South East of England11. All patients were of 
non-Caucasian ethnicity. Our study confirms that vitamin D deficiency cardiomyopathy is 
reversible with prompt identification and supplementation, in addition the use of ECLS is 
strongly indicated as a bridge to recovery in this cohort12.  The role of vitamin D and cardiac 
function is an area of increasing study, demonstrated by the VINDICATE (VitamIN D treatIng 
patients with Chronic heArT failurE) trial in the adult population with chronic heart failure. 
Witte et al demonstrated that administering high dose vitamin D in addition to optimal medical 
heart failure therapy increased left ventricular ejection fraction by 8%13.  
In spite of optimal medical management, our study confirms the first year of life is a critical 
period for outcome and other studies concur that a significant proportion of children will be re-
hospitalized and/or require cardiac transplantation within one year of presentation14,15. Puggia 
et al demonstrated an 82% survival at one year; 71% and 68% survival at six and nine years 
respectively. Their data also suggested that idiopathic DCM in the paediatric population has a 
poorer prognosis than the adult DCM population, even when the baseline left ventricular 
function was higher5. An Australian study by Daubenay et al reported freedom from death or 
transplantation at one and five years respectively; 72% and 63%. Risk factors for a poorer 
outcome included: familial dilated cardiomyopathy; age > 5 years at diagnosis and a lower 
fractional shortening at presentation16.  
An earlier study from our institution examining the outcome of DCM in the paediatric 
population of Scotland between 1980 and 1997 also reported all deaths occuring within the 
first year of life. Survival at one year and nine years was 69%17. Our recent study demonstrates 
that mortality in this cohort remains significant, but has improved in the modern era, 2000-
2015, with survival to one year 83.7%, and no cardiac deaths after one year in the current follow 
up. This may reflect continual improvements in the medical management of heart failure, 
advances in intensive care support and the provision of ECLS in our cardiac centre.  
Bharucha et al reported the risk of sudden cardiac death (SCD) in the DCM population at 5% 
(95% CI: 2% to 11%) after 15 years of follow up and increased risk if familial DCM, older age 
at diagnosis and lower fractional shortening at diagnosis 18. This study found no evidence of 
SCD once the left ventricular function had normalised. In addition, Dimas et al demonstrated 
a 1% risk of SCD in the paediatric idiopathic DCM population, in contrast to the adult DCM 
population ranging from 20-75%19. In the paediatric population with severe DCM, cardiac 
transplantation is the final recourse in the management of terminal heart failure14, with DCM 
continuing to be the most common indication for heart transplantation in children over the age 
of five 2. 
 
Limitations 
This cohort included all cases of dilated cardiomyopathy referred to a national centre however 
the study was retrospective and the sample size was small, therefore some data did not reach 
statistical significance. 
 
Conclusion 
Paediatric dilated cardiomyopathy is a heterogeneous disease, with an unidentified aetiology 
in around 50% of cases, resulting in significant morbidity. In the paediatric population the 
aetiology alters the age at presentation and identification is also a useful tool for risk 
stratification and prognostication.  The first year after a diagnosis of DCM is a critical time 
reflected in significant morbidity and mortality.  
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Table.1 Patient Demographics 
 
 
 
 
 
 
  
Demographics No. (%) 
Patients 43 
 Female 25 (58%) 
 Male 18 (42%) 
Ethnicity  
 Caucasian 35 (82%) 
 Black 4 (9%) 
 Asian  4 (9%) 
Aetiology  
 Idiopathic 22 (51.20%) 
 Viral 10 (23.30%) 
 Metabolic/Genetic 7 (16.30%) 
 Vitamin D Deficiency 4 (9.30%) 
Median age at diagnosis 10 mon; range= 0-42 
 Metabolic/Genetic 4 mon; range= 0-14 
 Vitamin D Deficiency 4.5 mon; range= 1-8 
 Viral 15 mon; range= 1-23 
 Idiopathic 11mon; range= 2-42 
Echocardiographic Features  
 Fractional shortening (mean) 11.5% 
 Ejection Fraction (mean) 29.1% 
 LVDED 42 mm 
Outcome  
 Transplant Referral 18 (41.90%) 
 Heart Transplantation 3 (7%) 
 Mortality 7 (16.3%) 
 Survival at 1 year  36 (83.7%) 
  
  
 
Figure 1 Median Age at Presentation 
 
 
 
Figure 2 Viral Aetiology 
0
2
4
6
8
10
12
14
16
G E N E T I C /  
M E T A B O L I C
V I T  D  D E F I C I E N C Y I D I O P A T H I C V I R A L
M
O
N
TH
S
AETIOLOGY
0
1
2
3
4
5
6
Parvovirus B19 (60%) Enteroviruses (30%) Mycoplasma
&Enterovirus (10%)
 Figure 3 Annual incidence of DCM. 
 
 
 
 
Figure 4 Seasonal Variation in Aetiology 
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Figure 5 Outcome after Referral for Transplant. 
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